Haemonetics (HAE) EBT (2009 - 2026)

Haemonetics' EBT history runs 18 years deep, the most recent figure standing at -$28.4 million for Q1 2026.

• In Q1 2026, EBT fell 140.15% year-over-year to -$28.4 million; the TTM figure through Mar 2026 stood at $128.0 million (down 39.63% YoY), while the FY2026 annual figure was $128.0 million, down 39.63% from the prior year.
• EBT was -$28.4 million for Q1 2026 at Haemonetics, down from $60.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $70.7 million in Q1 2025 to a low of -$28.4 million in Q1 2026.
• Historically, EBT has averaged $37.8 million across 5 years, with a median of $43.1 million in 2022.
• The sharpest annual moves came in 2022 and 2026: EBT soared 947.54% in 2022, then tumbled 140.15% in 2026.
• A 5-year view of EBT shows it stood at $42.2 million in 2022, then grew by 4.27% to $44.0 million in 2023, then gained by 13.37% to $49.9 million in 2024, then rose by 20.15% to $60.0 million in 2025, then tumbled by 147.35% to -$28.4 million in 2026.
• The last three EBT figures came in at -$28.4 million (Q1 2026), $60.0 million (Q4 2025), and $51.3 million (Q3 2025), per Business Quant data.